(864) 370-3297 info@glytecsystems.com

About
Solutions
Resources
Case Studies
Blog
Request a Demo

Evidence

The safety and efficacy of Glytec’s solutions have been validated by several dozen studies published in medical journals and presented at scientific conferences around the globe. We invite you to explore them here.

Filter by Topic

Hypoglycemia Reduction Inpatient Glycemic Management SubQ Insulin IV Insulin Length of Stay Reduction Diabetic Ketoacidosis (DKA) Resolution A1C Reduction Basal Bolus Adoption Cardiovascular Patients Cost of Care Reduction Hyperglycemia Reduction Staff Education Surgical Patients Academic Medical Center Connected Diabetes Technologies ICU Outpatient Glycemic Management Readmissions Reduction Research Study Virtual Care Clinical Surveillance POC Testing Time Savings Transition IV to SubQ Competitive Comparison Continuous Glucose Monitoring Emergency Department Glucommander™ H2H® (Hospital to Home) Heart Failure Patients Patients Without Diabetes

This is a search field with an auto-suggest feature attached.

There are no suggestions because the search field is empty.

Meal Replacements in Conjunction with an Integrated, Technology-Driven Strategy for Treatment of Patients with Diabetes in Rural, Underserved Areas: A Pilot Study

Read More

Glucometrics: Where Are We Now?

Read More

High-dose insulin infusion in patients with COVID-19

Read More

Clinical Outcomes Of Euglycemic Diabetic Ketoacidosis (euDKA) Treated With a Computerized Insulin Algorithm: Descriptive Analysis of a Nationwide Cohort

Read More

Hypoglycemia Treatment in the Hospital: The 15/15 Rule is Over

Read More

Transitioning Safely from Intravenous to Subcutaneous Insulin

Read More

Clinical Trials of COVID-19 Therapies Should Account for Diabetes and Hyperglycemia

Read More

The Power of Inpatient Glucometrics

Read More

Glycemic Outcomes for Adult Type 1 Diabetes (T1D) With and Without DKA

Read More

IV Insulin via Glucommander, eGlycemic Management System (eGMS), Demonstrates Low Rates of Hypoglycemia in Patients with Low eGFR Compared to Other Electronic Glycemic Management Tools

Read More

Characteristics of and Mortality Associated With Diabetic Ketoacidosis Among US Patients Hospitalized With or Without COVID-19

Read More

Remote Continuous Glucose Monitoring With a Computerized Insulin Infusion Protocol for Critically Ill Patients in a COVID-19 Medical ICU: Proof of Concept

Read More

Association between achieving inpatient glycemic control and clinical outcomes in hospitalized patients with COVID-19: a multicenter, retrospective hospital-based analysis

Read More

Continuous Glucose Monitors and Automated Insulin Dosing Systems in the Hospital Consensus Guideline

Read More

Utilization of Computer-Guided Insulin Dosing Reduces Hypoglycemia Adverse Drug Events, Length of Stay and Hospitalization Costs at a Large Pacific Northwest Health System

Read More

Improved Glycemic Control in the Hospital Using Computer-Driven eGylcemic Management System® Plus High-Reliability Strategies for Basal Bolus Subcutaneous Insulin Therapy

Read More

Reduction of Hypoglycemia Across 180 U.S. Hospitals Using eGlycemic Management System® for IV Insulin Therapy with ICU and non-ICU Patients

Read More

Sustained Hypoglycemia Reduction Using eGlycemic Management System® to Manage Insulin Infusion Therapy Among Critical Care Patients

Read More

Improved Patient Safety and Glycemic Outcomes in the ICU Using Computer-Guided Intravenous Insulin Therapy Versus Subcutaneous Insulin Therapy

Read More

Use of Technology Reduces Incidence of Hypoglycemia- Related Adverse Drug Events Among Patients Requiring Insulin Therapy While Hospitalized

Read More

Evaluating the Impact of Glucommander on Improvement in Time-in-Range (TIR) in Type 2 Diabetes using Continuous Glucose Monitoring

Read More

Glycemic Characteristics and Clinical Outcomes of COVID-19 Patients Hospitalized in the United States

Read More

Subcutaneous Insulin Dosing Calculators for Inpatient Glucose Control

Read More

Reducing Critical Hypoglycemia Through Quality Improvement Initiatives and Implementation of an eGlycemic Management System

Read More

Technology-Enabled Glycemic Management Leads to Reductions in Variation and Increased Use of Basal Bolus Regimens for Subcutaneous Insulin Therapy

Read More

Computer-Based Versus Paper-Based Insulin Infusion Algorithms in Diabetic Ketoacidosis

Read More

Comparison of Hyperglycemia Management Protocols in the ICU: Standard Protocol versus eGlycemic Management System

Read More

Financial Implications of Poor Glycemic Management & Improvement Strategies for Optimal Outcomes

Read More

Safety and Efficacy of eGlycemic Management System among Labor and Delivery Patients at a Not-for-Profit Hospital in Hawaii

Read More

Evaluating the Impact of eGMS Glucommander on Length of Stay, Hypoglycemia and Glucose Control in a Regional Medical Center

Read More

Blood Glucose Testing Frequency Correlates to A1c Reduction After 3 Months of Insulin Titration Utilizing Glucommander

Read More

Comparison of Computer-Guided Versus Standard Insulin Infusion Regimens in Patients with Diabetic Ketoacidosis

Read More

Safely Converting an Entire Academic Medical Center From Sliding Scale to Basal Bolus Insulin via Implementation of the eGlycemic Management System

Read More

Risk of Hypoglycemia During Insulin Infusion Directed by Paper Protocol Versus Electronic Glycemic Management System in Critically Ill Patients at a Large Academic Medical Center

Read More

Use of Decision Support Software to Titrate Multiple Daily Injections Yielded Sustained A1c Reductions After 1 Year

Read More

Utilization of Electronic Glucose Management Systems for Hospital Discharge Insulin Dosing

Read More

Prev 1 2 3 Next

Subscribe to our blog

Glytec is the insulin management software company for healthcare providers focused on improving the quality and cost of care. Its FDA-cleared titration software and proprietary algorithms power the only solution capable of delivering personalized diabetes treatment recommendations across the continuum of care, from hospital to home. With ongoing support from its team of doctors, nurses and technologists headquartered outside of Boston, Glytec improves outcomes and controls costs for the large population of patients requiring insulin treatment – including those with and without a diagnosis of diabetes.

Terms of Use
Legal Disclaimer
Privacy Policy
Contraindications, Warnings and Precautions

© 2023 Glytec, LLC on behalf of Aseko, Inc.

The eGlycemic Management System^® is a modularized solution for glycemic management across the care continuum that includes Glucommander^™. Glucommander^™ is a prescription-only software medical device for glycemic management intended to evaluate current as well as cumulative patient blood glucose values coupled with patient information including age, weight and height, and, based on the aggregate of these measurement parameters, whether one or many, recommend an IV dosage of insulin, glucose or saline or a subcutaneous basal and bolus insulin dosing recommendation to adjust and maintain the blood glucose level towards a configurable physician- determined target range. Glucommander^™ is indicated for use in adult and pediatric (ages 2-17 years) patients. The measurements and calculations generated are intended to be used by qualified and trained medical personnel in evaluating patient conditions in conjunction with clinical history, symptoms, and other diagnostic measurements, as well as the medical professional’s clinical judgement. No medical decision should be based solely on the recommended guidance provided by this software program.

Glucommander^™ is only available for use in the United States.

This site is only intended for use in the United States.

Aseko is a registered trademark of Aseko, Inc.